Mpirik Adds Renowned Cardiothoracic Surgeon, Dr. Daniel O’Hair, As Its Chief Medical Officer

MILWAUKEE, July 1, 2020 /PRNewswire/ — Mpirik, an A.I. healthcare technology company that develops automated patient screening models for cardiovascular disease to drive actionable knowledge, quality and research, has named Dr. Daniel O’Hair as its Chief Medical Officer.

For more than 20 years Dr. Daniel O’Hair has practiced as a Cardiovascular Surgeon, thought leader and scientific innovator both locally and nationally. He is widely published in the field of heart valve disease and is credited with many “firsts” in the area of robotic mitral valve repair as well as transcatheter solutions for both aortic and mitral valve disease. His dedication and leadership led to the creation of one of the largest, high performing heart valve programs in the United States. Leveraging a unique experience in both catheter based procedures and open heart surgery, he advises patients from a perspective that can be matched by only a few people in the world. Dr. O’Hair is currently the Director of Cardiovascular Surgery at Foothills Hospital, Boulder Community Health, Boulder, Colorado, where he sees patients with complex heart valve disease.

“Delivering high value heart care to patients in need has been the focus of my career. The Mpirik platform uniquely enables me to continue this work at scale by identifying patients and connecting them with expert care in a timely manner. The result is better patient outcomes.  It’s a win for everyone” commented Dr. O’Hair.

“We are elated to have Dr. O’Hair join Mpirik as the Chief Medical Officer”, said Joe Kohli, MD, Founder and Chief Executive Officer of Mpirik. “Dr. O’Hair’s expertise and innovative spirit will be an exceptional asset to the Mpirik team to help drive our product and data science forward.”

About Mpirik

Mpirik is the developer of a healthcare intelligence platform designed to identify critical findings, filter extraneous data and facilitate communication. The company’s platform aggregates health data, standardizes patient communication and tracks patient’s disease ensuring proper and timely follow-up. The platform algorithms augment the physician’s ability to deliver excellence by objectively screening patients with heart disease at scale and ensuring their connection to timely care.

 

View original content:http://www.prnewswire.com/news-releases/mpirik-adds-renowned-cardiothoracic-surgeon-dr-daniel-ohair-as-its-chief-medical-officer-301086270.html

SOURCE Mpirik

Staff

Recent Posts

HCA Healthcare Releases 2024 Annual Impact Report

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced…

12 mins ago

Gresham Worldwide, Inc. Announces New Head of Israeli Defense Subsidiary

Company Names Nissim Ovadia as CEO of Enertec Systems 2001, Ltd.SCOTTSDALE, Ariz. & KARMIEL, Israel--(BUSINESS…

13 mins ago

Mobix Labs Broadens Product Portfolio to Include Medical Technology Sector

--End Users include GE HealthCare and PerkinElmerIRVINE, Calif.--(BUSINESS WIRE)--Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs”…

14 mins ago

NervGen Completes $23 Million Bought Deal Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED…

15 mins ago

Red Light Holland Announces that MISTERCAP’S Mushroom Home Grow Kits Selected by Urban Outfitters for Nationwide Retail Distribution in the USA

Toronto, Ontario--(Newsfile Corp. - March 28, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE:…

15 mins ago

Akanda Corp. Announces Strategic Plan to Evaluate and Enter Bitcoin, Blockchain, AI Segments of the Cannabis Market

London, United Kingdom--(Newsfile Corp. - March 28, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or…

15 mins ago